Press releases
05.03.2026
Evogene Ltd.
Evogene Ltd. (Nasdaq, TASE: EVGN) is a pioneering computational chemistry company developing generative AI to design and optimize small molecules for the pharmaceutical and agricultural industries.
Latest Press Releases
Press releases
25.02.2026
Evogene Releases CEO Letter to Shareholders
Press releases
19.02.2026
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
Webcast registration
Webcast
Thu, March 5, 2026 | 9:00 am
Q4 and Full Year 2025 Financial Results Call
The Company’s management will host a Zoom conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time.
To join the conference, please register in advance.
Presentations
Evogene Company Presentation.
22.02.2026
Latest Financial Results
Q3 EARNINGS CALLS
Earnings Call Presentation
17.10.2025
Q3 2025 Earning Call
17.10.2025
Sign Up for Investor Relations Email Alerts
Investor Relations Contact
